Skip to main content
. Author manuscript; available in PMC: 2019 Oct 29.
Published in final edited form as: Pain Med. 2011 Apr 11;12(5):697–705. doi: 10.1111/j.1526-4637.2011.01096.x

Table 1.

Demographics of the MSH sample (N=299)

Group Hydroxyurea
(n=152)
Placebo
(n=147)
% %
Sex:
  Male 49.3 48.3
  Female 50.7 51.7
Χ2(1)=0.033, p=.86
Education:
  Less than high school 17.8 18.4
  High school/GED 33.6 38.1
  Some college 44.1 38.8
  B.A./postgraduate degree   4.6   4.8
Χ2(3)=0.96, p=.81
Personal income:
  Less than 10,000 65.3 73.3
  10,000–19,999 20.4 18.5
  20,000–29,999 7.5 3.4
  30,000–39,999 4.8 3.4
  40,000–49,999 2.0 1.4
Χ2(4)=3.53, p=.47
Employment
  Full-time 19.5 17.4
  Part-time 13.4 18.1
  Unemployed/disabled 62.4 58.3
  Student (full or part-time) 4.7 6.3
Χ2(3)=1.70, p=.64
Age at qualifying visit
Mean (standard deviation) 30.6 (7.54) 29.8 (7.47)
Range 18–59 18–54
t(297)=0.93, p=.35